京都府立医科大学神経内科は、神経内科、老年内科、脳卒中診療科領域の疾患の診療・教育・研究に全力で取り組んでいます。

神経内科教室について

業績一覧へ

【2016年】

著書

    [Ⅰ] 著 書
    1. 山本康正.ラクナ梗塞およびbranch atheromatous disease の急性期治療はどうしますか?神経内科Clinical Questions & Pearls脳血管障害.P: 96-10. 鈴木則宏 監修.
    2. 山本康正.第2章 G神経疾患 脳梗塞.内科診療実践マニュアル.日本臨床内科医会編.日本医学出版 pp.480-484.
    3. 塩貝敏之.アルツハイマー病.イヤーノート・アトラス 第6版.東京:メディックメディア pp. J26,2016.
    4. 塩貝敏之.慢性硬膜下血腫.イヤーノート・アトラス 第6版.東京:メディックメディア pp. J62, 2016.
    5. 中川正法.Charcot-Marie-Tooth病.田村 晃 他編.EBMに基づく脳神経疾患の基本治療指針 第4版.メジカルビュー社,東京,pp630-636, 2016.
    6. 中川正法.Charcot-Marie-Tooth病.土屋弘行 他編.今日の整形外科治療指針 第7版.医学書院,東京,pp290, 2016.
    7. 平澤泰介,武澤信夫.地域包括ケアとリハビリテーション―京都プロジェクトの推進を中心に―.最新リハビリテーション(編集主幹:平澤泰介,椿原彰夫,才藤栄一,水間正澄). 東京:株式会社シナノパブリッシングプレス pp.30-32,2016.
    8. Tokuda T, Ishii R, Tatebe H, Kasai T, El-Agnaf OMA. Alpha-Synuclein in Cerebrospinal Fluid. Kenji Kosaka (Eds). Dementia with Lewy Bodies. Tokyo: Springer Japan, 2016. (in press)
    9. 徳田隆彦. 特発性正常圧水頭症. 医学書院編. 今日の治療指針 2017年版―私はこう治療している. 東京:医学書院 2017. (in press)
    10. 山本敏之,巨島文子.筋炎・筋疾患.摂食嚥下リハビリテーション第3版.東京:医歯薬出版 pp.312-315, 2016.
    11. 尾原知行.静注血栓溶解療法.豊田一則,古賀政利 編.SCUグリーンノート.東京:中外医学社 pp.225-232,2016.
    12. 横関恵美,浦部博志, 垣田清人.脳血管障害.3ステップでわかるリハビリ病棟の疾患・リハ・看護まるごとブック. 大阪:メディカ出版 pp.48-62, 2016.
    13. 徳田直輝,古賀政利.SCUで出会う事例 十番勝負 大動脈解離を併発した脳梗塞患者.豊田一則,古賀政利 編.SCUグリーンノート.東京:中外医学社 pp.319-322,2016.

    ページの先頭へ

    総説

      [Ⅱ] 総 説
      1. 中川正法.CMTの治療―神経内科の立場から.Brain and Nerve, 68(1): 43-50, 2016.
      2. 中川正法.単純ヘルペス脳炎診療ガイドライン.化学療法の領域,32(S-1):756-761, 2016.
      3. 中川正法.シャルコー・マリー・トゥース病の遺伝子診断の進歩と治療戦略.日内会誌,105(9): 1855-1863, 2016.
      4. 武澤信夫.京都式地域包括ケアシステムと地域リハビリテーション・コーデイネータの重要性.臨床リハ,25(4): 377-384,2016.
      5. 武澤信夫.京都地域リハビリテーション研究会―京都における回復期リハビリテーション病棟整備に向けた動向.回復期リハビリテーション,15: 51-53,2016.
      6. 徳田隆彦.特集「認知症診療・研究のtopics」アルツハイマー病の病態発現仮説:そのparadigm shift. 京都府立医科大学雑誌,125(12): 797-804, 2016.
      7. 徳田隆彦.Controversies: メタボロームはパーキンソン病のバイオマーカーとして有用か?:「NO」の立場から.Frontiers in Parkinson Disease, 2017. (in press)
      8. 水田依久子,水野敏樹.特集「認知症診療・研究のtopics」脳小血管病からみた血管性認知症.京都府立医科大学雑誌,125(12): 805-812, 2016.
      9. 谷口 洋,宮川晋治,巨島文子,辻有希子,倉智雅子,中平真矢,兵頭政光.症例 私の治療方針 羞明,眼瞼下垂および球症状を呈した75歳女性例.嚥下医学,5巻1号:14-19, 2016.
      10. 小山晃英,渡邊能行,栗山長門.脳血管からみた血管作動性生理ペプチドの新しい役割.神経内科,84: 550-556, 2016.
      11. 近藤正樹.失行の診方を考える.神経心理学,32(3): 216-223, 2016.
      12. 近藤正樹.後頭葉の読み書き障害.神経心理学,32(4): 311-321, 2016.
      13. 中村智実,後藤太郎.アルツハイマー型認知症におけるsolanezumabの臨床開発状況と今後の展望.Current Therapy, 34: 258-264, 2016.
      14. 中村智実,松本圭奈,植田 要,丹治由佳,並木千尋. florbetapir(18F)によるアミロイドPETのアルツハイマー型認知症の診断における有用性.精神医学,58: 277-287, 2016.
      15. 中村智実,岩田 淳,植田 要,並木千尋.アルツハイマー型認知症におけるflorbetapir(18F)を用いたアミロイドイメージングの臨床的意義と適正使用. BRAIN and NERVE, 68: 1215-1222, 2016.
      16. 吉田誠克.指定難病最前線「アレキサンダー病の診断と現状」.新薬と臨床,65巻7: 83-88,2016.
      17. 笠井高士,徳田隆彦.【内科医がおさえておくべきパーキンソン病診療のポイント】パーキンソン病とパーキンソン症候群の鑑別のための検査 パーキンソン病および診断パーキンソン症候群のバイオマーカー(血液・髄液).内科,118: 251-254,2016.
      18. 笠井高士,徳田隆彦.パーキンソン病の早期診断.神経内科.(in press)
      19. 濱中正嗣,今井啓輔.【脳神経領域で必須のくすり ナース版トリセツ】(第1章)脳神経疾患治療のくすり 脳卒中治療のくすり 脳卒中の治療概論,血栓溶解薬.Brain Nursing, 2016夏季増刊: 8-11,2016.
      20. 尾原知行,水野敏樹.非心原性脳梗塞の一次予防と二次予防.medicina, 53巻:297-300, 2016.
      21. 丹羽文俊,島田斉.認知症診断におけるタウPETの意義.Medical Imaging Technology,34: 22-25,2016.
      22. Noto Y,Shibuya K,Vucic S,Kiernan MC. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis. Expert Rev Neurother.16(10): 1147-54,2016.
      23. Simon N,Noto Y,Zaidman CM.Skeletal muscle imaging in neuromuscular disease.J Clin Neurosci. 33: 1-10, 2016.
      24. Shahrizaila N,Sobue G,Kuwabara S,Kim SH,Birks C,Fan DS,Bae JS,Hu CJ,Gourie-Devi M,Noto Y,Shibuya K,Goh KJ,Kaji R,Tsai CP,Cui L,Talman P,Henderson RD,Vucic S,Kiernan MC. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J Neurol Neurosurg Psychiatry. 87(8): 821-30,2016.
      25. Yamaguchi M, Azuma Y,Yoshida H. ALS and cancer. J Carcinog Mutagen. 7: e122. doi: 10.4172/2157-2518.1000e122, 2016.
      26. 建部陽嗣,樋川正仁.『現代中国医学の成功の要因』の書から「モダン (現代) 鍼灸」の構造を読む.医道の日本,75(1): 234-236, 2016.
      27. 建部陽嗣,樋川正仁.鍼灸の論文数は中国が圧勝 日本の研究界には新星登場.医道の日本,75(2): 174-176, 2016.
      28. 建部陽嗣,樋川正仁.病院で鍼治療を受けた患者を調査したシンガポールの研究. 医道の日本,75(3): 144-146, 2016.
      29. 建部陽嗣,樋川正仁.神経変性疾患への鍼刺激研究を掘り下げた新論文.医道の日本,75(4): 170-172, 2016.
      30. 建部陽嗣,樋川正仁.脳の炎症によるうつ病を鍼治療が改善させる.医道の日本,75(5): 169-171, 2016.
      31. 建部陽嗣,樋川正仁.鍼治療の機序研究に新たな手法-メタボロミクスによる網羅的解析.医道の日本,75(6): 174-176, 2016.
      32. 建部陽嗣,樋川正仁.台湾の研究者による最新レビューで耳鍼が再び脚光を浴びる.医道の日本,75(7): 159-161, 2016.
      33. 建部陽嗣,樋川正仁.韓国の研究者が検証した灸による熱傷の特徴.医道の日本,75(8): 160-162, 2016.
      34. 建部陽嗣,樋川正仁.痛み治療に求められるEBM-鍼治療にできる追従と独創の道.医道の日本,74(9): 147-149, 2016.
      35. 建部陽嗣,樋川正仁.鼻づまり治療の新たな手法 翼口蓋神経節刺鍼.医道の日本, 75(10): 162-164, 2016.
      36. 建部陽嗣,樋川正仁.鍼による術後イレウス予防のシステマティックレビュー.医道の日本,75(11): 151-153, 2016.
      37. 建部陽嗣,樋川正仁.「便秘に鍼通電」の海外論文を宣伝に使う日本人鍼灸師の愚行.医道の日本,75(12): 164-166, 2016.

      ページの先頭へ

      英文原著

        [Ⅲ] 原 著
        <英文原著>
        1. Yamamoto Y, Nagakane Y, Tomii Y, Akiguchi I. High Morning and Bedtime Home Blood Pressures Strongly Predict for Post-Stroke Cognitive Impairment. J Stroke Cerebrovasc Dis. 25: 1856-63. 2016.
        2. Yamamoto Y. High bedtime home blood pressure strongly predicts post stroke cognitive impairment. Atlas of Science. September 14, 2016.
        3. Shiogai T, Koyama M, Yamamoto M, Arima Y, Maejima R, Kasai T, Mizuno T, Nakagawa M. Determining Differences in Correlation of Ultrasound Wave Intensity Analysis in the Cervical Arteries with Intracranial Hemodynamics. Neurosonology 29: 122-123, 2016. (abstract)
        4. Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, Nakagawa M, Suzuki Y, Matsuoka M. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT). PLoS Pathog. 12(1): e1005372. doi: 10.1371/journal.ppat.1005372, 2016.
        5. Higuchi Y, Hashiguchi A, Yuan J, Yoshimura A, Mitsui J, Ishiura H, Tanaka M, Ishihara S, Tanabe H, Nozuma S, Okamoto Y, Matsuura E, Ohkubo R, Inamizu S, Shiraishi W, Yamasaki R, Ohyagi Y, Kira JI, Oya Y, Yabe H, Nishikawa N, Tobisawa S, Matsuda N, Masuda M, Kugimoto C, Fukushima K, Yano S, Yoshimura J, Doi K, Nakagawa M, Morishita S, Tsuji S, Takashima H. Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2. Ann Neurol. doi: 10.1002/ana.24612, 2016. [Epub ahead of print]
        6. Sugata K, Yasunaga J, Miura M, Akari H, Utsunomiya A, Nosaka K, Watanabe Y, Suzushima H, Koh KR, Nakagawa M, Kohara M, Matsuoka M. Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sci Rep. 6: 27150. doi: 10.1038/srep27150, 2016.
        7. Mizuno T, Mizuta I, Tomimoto H. Evaluation of NOTCH3 Pro167Ser Variation in a Japanese Family with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. Dement Geriatr Cogn Disord Extra. 6: 183-184, 2016.
        8. Tojima M, Saito S, Yamamoto Y, Mizuno T, Ihara M, Fukuda H. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy with a Novel NOTCH3 Cys323Trp Mutation Presenting Border-Zone Infarcts: A Case Report and Literature Review. J stroke cerebrovasc dis. 25(8): e128-130, 2016.
        9. Konno T, Yoshida K, Mizuno T, Kawarai T, Tada M, Nozaki H, Ikeda S, Nishizawa M, Onodera O, Wszolek Zbigniew, Ikeuchi T. Clinical and genetic characterization of Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia associated with CSF1R mutation. European Neurology. (in press)
        10. Ito K, Iwamoto K, Sato Y, Fujita T, Takahashi K, Katano H, Hasegawa H, Takasaki T, Tando S, Fushiki S. Knowledge Obtained from an Elderly Case of Japanese Encephalitis. Intern Med. 55: 2487-2490, 2016.
        11. Chambers JK, Tokuda T, Uchida K, Ishii R, Tatebe H, Takahashi E, Tomiyama T, Une Y, Nakayama H. The domestic cat as a natural animal model of Alzheimer’s disease. Acta Neuropathol Commun. 3(1): 78, 2015.
        12. Majbour NK, Vaikath NN, van Dijk KD, Ardah MT, Varghese S, Vesterager LB, Montezinho LP, Poole S, Safieh-Garabedian B, Tokuda T, Teunissen CE, Berendse HW, van de Berg WD, El-Agnaf OM. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease. Mol Neurodegener. 11(1): 7, 2016.
        13. Yamada S, Ishikawa M, Miyajima M, Atsuchi M, Kimura T, Kazui H, Mori E; SINPHONI-2 Investigators. Disease duration: the key to accurate CSF tap test in iNPH. Acta Neurol Scand. doi: 10.1111/ane.12580, 2016. [Epub ahead of print]
        14. Yamada S, Kimura T, Jingami N, Atsuchi M, Hirai O, Tokuda T, Miyajima M, Kazui H, Mori E, Ishikawa M, SINPHONI-2 Investigators. Disability risk or unimproved symptoms following shunt surgery in patients with iNPH: Post Hoc Analysis of SINPHONI-2. J Neurosurg. 2016 Jul 15: 1-8.
        15. Majbour NK, Vaikath NN, Eusebi P, Chiasserini D, Ardah M, Varghese S, Haque ME, Tokuda T, Auinger P, Calabresi P, Parnetti L, El-Agnaf OMA. Longitudinal changes in CSF alpha-synuclein species reflect Parkinson’s disease progression. Mov Disord. 2016. (in press)
        16. Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C. Biochemical diagnosis of Parkinson’s disease by detection of α-synuclein misfolded aggregates in cerebrospinal fluid. JAMA neurol. 2016. (in press)
        17. Yamada S, Ishikawa M, Miyajima M, Nakajima M, Atsuchi M, Kimura T, Tokuda T, Kazui H, Mori E. Timed up and go test at tap test and shunt surgery in idiopathic normal pressure hydrocephalus. Neurol Clin Pract. 2016. (in press)
        18. Majbour NK, Chiasserini D, Vaikath NN, Eusebi P, Tokuda T, van de Berg W, Parnetti L, Calabresi P, El-Agnaf OMA. Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease. Sci Rep. (in press)
        19. Suda S, Okubo S, Ueda M, Sowa K, Abe A, Aoki J, Muraga K, Suzuki K, Sakamoto Y, Mizuta I, Mizuno T, Kimura K. A Japanese CADASIL kindred with a novel two-base NOTCH3 mutation. Eur J Neurol. 23(5): e32-4, 2016.
        20. Nozaki H, Kato T, Nihonmatsu M, Saito Y, Mizuta I, Noda T, Koike R, Miyazaki K, Kaito M, Ito S, Makino M, Koyama A, Shiga A, Uemura M, Sekine Y, Murakami A, Moritani S, Hara K, Yokoseki A, Kuwano R, Endo N, Momotsu T, Yoshida M, Nishizawa M, Mizuno T, Onodera O. Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology. 86(21): 1964-74, 2016.
        21. Ando T, Goto Y, Mano K, Ueda A, Ando Y, Mizuta I, Mizuno T. CADASIL Presenting as Acute Bilateral Multiple Subcortical Infarcts without a Characteristic Temporal Pole or Any External Capsule Lesions. Intern Med. (in press)
        22. Watanabe I, Kuriyama N, Miyatani F, Nomura R, Naka S, Nakano K, Ihara M, Iwai K, Matsui D, Ozaki E, Koyama T, Nishigaki M, Yamamoto T, Tamura A, Mizuno T, Akazawa K, Takada A, Takeda K, Yamada K, Nakagawa M, Tanaka T, Kanamura N, Friedland RP, Watanabe Y. Oral Cnm-positive Streptococcus Mutans Expressing Collagen Binding Activity is a Risk Factor for Cerebral Microbleeds and Cognitive Impairment. Sci Rep. 6: 38561, 2016.
        23. Kuriyama N, Mizuno T, Yasuike H, Matsuno H, Kawashita E, Tamura A, Ozaki E, Matsui D, Watanabe I, Koyama T, Miyatani F, Kondo M, Tokuda T, Ohshima Y, Muranishi M, Akazawa K, Takada A, Takeda K, Matsumoto S, Mizuno S, Yamada K, Nakagawa M, Watanabe Y. CD62-mediated activation of platelets in cerebral white matter lesions in patients with cognitive decline. Arch Gerontol Geriatr. 62: 118-124, 2016.
        24. Tonomura S, Ihara M, Kawano T, Tanaka T, Okuno Y, Saito S, Friedland RP, Kuriyama N, Nomura R, Watanabe Y, Nakano K, Toyoda K, Nagatsuka K. Intracerebral hemorrhage and deep microbleeds associated with cnm-positive Streptococcus mutans; a hospital cohort study. Sci Rep. 6: 20074, 2016.
        25. Koyama T, Kuriyama N, Ozaki E, Matsui D, Watanabe I, Miyatani F, Kondo M, Tamura A, Kasai T, Ohshima Y, Yoshida T, Tokuda T, Mizuta I, Mizuno S, Yamada K, Takeda K, Matsumoto S, Nakagawa M, Mizuno T, Watanabe Y. Serum albumin to globulin ratio is related to cognitive decline via reflection of homeostasis: a nested case-control study. BMC Neurol. 16: 253, 2016.
        26. Uemura H, Katsuura-Kamano S, Yamaguchi M, Arisawa K, Hamajima N, Hishida A, Kawai S, Oze I, Shinchi K, Takashima N, Suzuki S, Nakahata N, Mikami H, Ohnaka K, Kuriyama N, Kubo M, Tanaka H; Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group. A variant of the CLOCK gene and related haplotypes are associated with the prevalence of type 2 diabetes in the Japanese population. J Diabetes. 8: 667-676, 2016.
        27. Fukuda S, Kuriyama N, Tsuru H, Egawa M. Immediate effects of acupuncture on tongue pressure including swallowing reflex latency in Parkinson’s disease. Acupunct Med. 34: 59-61, 2016.
        28. Horii M, Fujiwara H, Mikami Y, Ikeda T, Ueshima K, Ikoma K, Shirai T, Nagae M, Oka Y, Sawada K, Kuriyama N, Kubo T. Differences in monthly variation, cause, and place of injury between femoral neck and trochanteric fractures: 6-year survey (2008–2013) in Kyoto prefecture, Japan. Clin Cases Miner Bone Metab. 13: 19-24, 2016.
        29. Matsui D, Yamamoto T, Nishigaki M, Miyatani F, Watanabe I, Koyama T, Ozaki E, Kuriyama N, Kanamura N, Watanabe Y. Validity of self-reported number of teeth and oral health variables. BMC Oral Health. 17: 17, 2016.
        30. Nishida Y, Hara M, Sakamoto T, Shinchi K, Kawai S, Naito M, Hamajima N, Kadota A, Suzuki S, Ibusuki R, Hirata A, Yamaguchi M, Kuriyama N, Oze I, Mikami H, Kubo M, Tanaka H; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.Influence of cigarette smoking and inflammatory gene polymorphisms on glycated hemoglobin in the Japanese general population. Prev Med Rep. 3: 288-295, 2016.
        31. Kuriyama N, Ihara M, Mizuno T, Ozaki E, Matsui D, Watanabe I, Koyama T, Kondo M, Tokuda T, Tamura A, Yamada K, Akazawa K, Takeda K, Takada A, Mizuno S, Nakagawa M, Watanabe Y. Association between mid-regional proadrenomedullin levels and progression of deep white matter lesions in the brain accompanying cognitive decline. J Alzheimers Dis. 2016. (in press)
        32. Kuriyama N, Miyajima M, Nakajima M, Kurosawa M, Fukushima W, Watanabe Y, Ozaki E, Hirota Y, Tamakoshi Akiko, Mori E, Kato T, Tokuda T, Urae A, Arai H. Nationwide epidemiologic survey of idiopathic normal pressure hydrocephalus (iNPH) in Japan: The Epidemiological and clinical characteristics. Brain Behav. 2016. (in press)
        33. Matsui D, Watanabe I, Koyama T, Ozaki E, Kuriyama N, Mizuno S, Watanabe Y. Japanese female Kendo practitioners are associated with high radial bone mineral density. J Sports Sci. 2016. (in press)
        34. Nakase T, Tobisawa M, Sasaki M, Suzuki A. Outstanding symptoms of poststroke depression during the acute phase of stroke. Plos One. 11: e0163038, 2016.
        35. Endo T, Nakase T, Sasaki M, Ishikawa T. Impact of extraischemic hemorrhage after thrombolysis with intravenous recombinant tissue plasminogen activity. J Neurol Neurosci. 7: S3, 2016.
        36. Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H, Terasaki T, Yoshimura S, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Nagakane Y, Kameda T, Hasegawa Y, Shibuya S, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Matsuki T, Homma K, Takasugi J, Tokunaga K, Sato S, Kario K, Kitazono T, Toyoda K; SAMURAI Study Investigators. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Int J Stroke. 11(5): 565-74, 2016.
        37. Koga M, Yoshimura S, Hasegawa Y, Shibuya S, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Todo K, Kimura K, Furui E, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Yagita Y, Kario K, Shiozawa M, Sato S, Yamagami H, Arihiro S, Toyoda K; SAMURAI Study Investigators. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation. Stroke. 47(10): 2582-2588, 2016.
        38. Matsuo K, Fujii C, Miyata K, Segawa Y, Kado H, Hatta T, Sato Y, Yasuda R, Nakagawa M, Mizuno T.A case of refractory generalized myasthenia gravis treated with polypharmacy and plasma exchange.J Neurol Neurophysiol.7: 2, 2016.
        39. Ogura H, Maki F, Sasaki N, Yoshida T, Hasegawa Y. Familial adult-onset Alexander disease with a novel GFAP mutation. Mov Disord Clin Prac.3: 300-302, 2016.
        40. Kasai T, Tokuda T, Ohmichi T, Ishii R, Tatebe H, Nakagawa M, Mizuno T. Serum levels of coenzyme Q10 in patients with multiple system atrophy. PLoS One. 11: e0147574, 2016.
        41. Sakaue S, Kasai T, Mizuta I, Osone S, Azuma Y, Imamura T, Tokuda T, Kannno H, Morimoto M, El-Agnaf O.M.A, Nakagawa M, Hosoi H, Mizuno T. Early-onset Parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: Do PGK-1 mutations contribute to vulnerability to parkinsonism? npj Parkinson Disease. (in press)
        42. Ohara T, Koga M, Tokuda N, Tanaka E, Yokoyama H, Minatoya K, Nagatsuka K, Toyoda K, Minematsu K. Rapid identification of Type A aortic dissection as a cause of acute ischemic Stroke. J Stroke Cerebrovasc Dis. 25: 1901-1906, 2016.
        43. Sakamoto Y, Koga M, Ohara T, Ohyama S, Matsubara S, Minatoya K, Nagatsuka K, Toyoda K. Frequency and Detection of Stanford Type A Aortic Dissection in Hyperacute Stroke Management. Cerebrovasc Dis. 42: 110-116, 2016.
        44. Muranishi M, Mori S, Fujiwara Y. A case of idiopathic normal pressure hydrocephalus (iNPH) with the comorbidity of progressive supranuclear palsy (PSP) confirmed by 123I-FP-CIT SPECT. Matsushita Medical Journal. 54(2): 76-78, 2016.
        45. Niwa F, Kondo M, Sakurada K, Nakagawa M, Imanishi J, Mizuno T. Regional cerebral blood flow in [123]I-IMP single-photon emission computed tomography and the Wechsler Memory Scale-revised in nondemented elderly subjects with subjective cognitive impairment. Intern Med. 55: 3571-3578, 2016.
        46. Kimura Y, Seki C, Ikoma Y, Ichise M, Kawamura K, Takahata K, Moriguchi S, Nagashima T, Ishii T, Kitamura S, Niwa F, Endo H, Yamada M, Higuchi M, Zhang MR, Suhara T. [(11)C]TASP457, a novel PET ligand for histamine H3 receptors in human brain. Eur J Nucl Med Mol Imaging. 43: 1653-1663, 2016.
        47. Ohara R, Imamura K, Morii F, Egawa N, Tsukita K, Enami T, Shibukawa R, Mizuno T, Nakagawa M, Inoue H. Modeling drug-induced neuropathy using human iPSCs for predictive toxicology. Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.562, 2016.
        48. Fujii C, Kondo T, Ochi H, Okada Y, Hashi Y, Adachi T, Shin-Ya M, Matsumoto S, Takahashi R, Nakagawa M, Mizuno T.Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy. Sci Rep.6: 35314, 2016.
        49. Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, Schrooten M, Van Damme P, Gawel M, Sonoo M, Higashihara M, Noto Y, Kuwabara S, Kiernan MC, Macaskill P, Vucic S. Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data. Clin Neurophysiol.127(7): 2684-91, 2016.
        50. Shahrizaila N, Noto Y, Simon NG, Huynh W, Shibuya K, Matamala JM, Dharmadasa T, Devenney E, Kennerson ML, Nicholson GA, Kiernan MC. Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy. Clin Neurophysiol.2016. (in press)
        51. Shibuya K, Misawa S, Kimura H, Noto Y, Sekiguchi Y, Iwai Y, Shimizu T, Mizuno T, Nakagawa M, Kuwabara S. Increased motor axonal persistent sodium currents predict rapid functional declines in amyotrophic lateral sclerosis. Neurology and Clinical Neuroscience.4(3): 108-11, 2016.
        52. Shibuya K, Park SB, Geevasinga N, Menon P, Howells J, Simon NG, Huynh W, Noto Y, Gotz J, Kril JJ, Ittner LM, Hodges J, Halliday G, Vucic S, Kiernan MC. Motor cortical function determines prognosis in sporadic ALS. Neurology.87(5): 513-20, 2016.
        53. Shibuya K, Park SB, Howells J, Huynh W, Noto Y, Shahrizaila N, Matamala JM, Vucic S, Kiernan MC. Laterality of motor cortical function measured by transcranial magnetic stimulation threshold tracking. Muscle Nerve. 2016. (in press)
        54. Kyotani A, Azuma Y, Yamamoto I, Yoshida H, Mizuta I, Mizuno T, Nakagawa M, Tokuda T, Yamaguchi M. Knockdown of the drosophila FIG4 induces deficient locomotive behavior, shortening of motor neuron, axonal targeting aberration, reduction of life span and defects in eye development. Exp Neurol. 277: 86-95, 2015.
        55. Yoshihara A, Fukatsu M, Hoshi K, Ito H, Yamaguchi Y, Ishii R, Tokuda T, Miyajima M, Arai H, Kato T, Furukawa K, Arai H, Kikuchi A, Takeda A, Ugawa Y, Hashimoto Y. Subgroup differences in “brain-type” transferrin and α-synuclein in Parkinson’s disease and multiple system atrophy. J Biochem. 2016. (in press).
        56. Murakami K, Tokuda M, Suzuki T, Irie Y, Hanaki M, Izuo N, Monobe Y, Akagi K, Ishii R, Tatebe H, Tokuda T, Maeda M, Kume T, Shimizu T, Irie K. Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer’s disease diagnosis. Sci Rep. 6: 29038, 2016.
        57. Kimura T, Miura T, Aoki K, Saito S, Hondo H, Konno T, Uchiyama A, Ikeuchi T, Takahashi H, Kakita A. Familial idiopathic basal ganglia calcification: Histopathologic features of an autopsied patients with an SLC20A2 mutation. Neuropathology 36: 365-371, 2016.
        58. Tsuji Y, Noto Y, Shiga K, Yokota I, Nakagawa M, Mizuno T. Does hand dominance affect peripheral nerve excitability? Clin Neurophysiol.127(4): 1921-2, 2016.
        59. Numa S, Kasai T, Kondo T, Kushimura Y, Kimura A, Takahashi H, Morita K, Tanaka A, Noto Y, Ohara T, Nakagawa M, Mizuno T.An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals. Intern Med. 55(6): 699-702, 2016.
        60. Takahashi H, Noto Y, Makita N, Kushimura-Okada Y, Ishii R, Tanaka A, Ohara T, Nakane S, Higuchi O, Nakagawa M, Mizuno T.Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports.BMC Neurol. 16(1): 229, 2016.
        61. Ioku T, Imai K, Hamanaka M, Yamazaki H, Itsukage M, Tsuto K, Yamamoto A, Nakamura T, Takegami T, Yamada T, Ikeda E. A case of Mechanical Thrombectomy with Stent-retriver Avoiding Vessel Linearization for Occuludede Tortuous Distal Branch of Middle Cerebral Artery(M2). Journal of Neuroendovascular Therapy. 10: 218-224, 2016.

        <和文原著>
        1. 中島健二.再考 高齢社会と認知症 ①日本はいつから高齢社会になったのでしょう.知恩,863: 28-31, 2016.
        2. 中島健二.再考 高齢社会と認知症 ②認知症の監督責任は誰に?知恩,864: 28-31, 2016.
        3. 中島健二.再考 高齢社会と認知症 ③先生、キカイばかり見ていないで私を診て.知恩,865: 28-31, 2016.
        4. 中島健二.再考 高齢社会と認知症 ④認知症にたくさんの種類があるって本当ですか.知恩,866: 28-31, 2016.
        5. 中島健二.再考 高齢社会と認知症 ⑤知識と知恵(街で出会ったご婦人).知恩,867: 28-31, 2016.
        6. 中島健二.再考 高齢社会と認知症 ⑥あなたは代わって下さったのだ.知恩,868: 28-31, 2016.
        7. 中島健二.再考 高齢社会と認知症 ⑦あなたのお値段はいくらですか? 知恩,869: 28-31, 2016.
        8. 中島健二.再考 高齢社会と認知症 ⑧認知症にならない法.知恩,870: 28-31, 2016.
        9. 中島健二.再考 高齢社会と認知症 ⑨認知症にならない法(2).知恩,871: 28-31, 2016.
        10. 平野哲雄, 武澤信夫, 東小百合, 梅田匡純, 安達徹, 吉岡 修, 中川正法. 高次脳機能障害者の日中活動の活性化と社会参加を進めるために 京都府北部(丹後二次医療圏)の実情をふまえて.京都医学会雑誌,62(2), 85-90, 2015.
        11. 山本康正.書評「脳卒中症候群」.BRAIN and NERVE, 68: 632, 2016.
        12. 山本康正.CREST試験:頸動脈狭窄症における頸動脈剥離と頸動脈ステントの両治療における長期追跡.Care Netジャーナル四天王,2016年3月18日.
        13. 山本康正.診察室の窓辺から 24時間血圧.血圧,23: 66-67. 2016.
        14. 森 敏,植村小夜子,伊丹君和,畑中裕司.在宅療養者への看護診断適用:診断ラベル選定とアセスメントリスト作成.人間看護学研究,14巻31-40,2016.
        15. 杉本英造,平位喜七郎,徳永千恵美,水野 恵,郷原憲一,安野哲也,有井悦子.平成27年度 精神衛生研究会事業報告.京都市学校医会誌,第26号:22-24, 2017.
        16. 松井大輔,渡邉 功,眞野 功,小山晃英,尾崎悦子,栗山長門,水野成人,渡邊能行.男性剣道有段者における橈骨骨密度の検討.日本骨粗鬆症学会,2: 41-47, 2016.
        17. 中村智実,今川英之,竹綱正典,塚本はるな,並河由夏,山崎裕義.日常診療下における小児期の注意欠陥/多動性障害患者に対するatomoxetineの安全性および有効性の評価 広汎性発達障害の併存例と非併存例の部分集団解析.臨床精神薬理,19: 335-346, 2016.
        18. 中村智実,今川英之,多喜田保志.成人期ADHD患者におけるアトモキセチンの早期反応性とその後の臨床経過に関する研究.Prog. Med. 36: 261-268, 2016.
        19. 永金義成,武澤秀理,桂 奏,山本康正.非細菌性血栓性心内膜炎により多発脳血管閉塞をきたした1剖検例.臨床神経学,56: 191-195,2016.
        20. 永金義成.頚動脈mobile plaqueを有する網膜中心動脈閉塞の症例[内科医の立場から].脳神経外科速報,26: 1300, 2016.
        21. 山下真澄,有馬有香,習田涼介,古畑和紘,山本真佑実,笠井高士,水野敏樹,塩貝敏之.頸部内頚動脈分枝異常動脈と椎骨脳底動脈系の形成不全を伴った1例.Neurosonology, 29(1): 58-61, 2016.
        22. 濱中正嗣,今井啓輔. 脳卒中治療のくすり(脳卒中の治療概論,血栓溶解薬).ブレインナーシング.
        23. 田中弘二,上原敏志,小林潤平,尾原知行,長束一行,峰松一夫,豊田一則.一過性脳虚血発作で入院中に発症した虚血性脳卒中に対しrt-PA 静注療法を施行した症例の検討.脳卒中,38:226-232,2016.
        24. 石井亮太郎,藤並 潤,松浦 潤,藤井明弘,中川正法,水野敏樹.片頭痛予防療法の減量中止の可否と予測因子の検討.日本頭痛学会誌,42: 171-176,2016.
        25. 辻有希子,能登祐一,滋賀健介,水野敏樹,中川正法.抗ガングリオシド抗体陽性であった筋萎縮性側索硬化症患者の検討.末梢神経,26(2): 359, 2015.
        26. 大道卓摩,近藤正樹,冨井康宏,高ノ原恭子,水野敏樹.急性期脳卒中患者における「急性期失語症評価シート」の試用.神経内科,85(6): 666-668, 2016.
        27. 中島大輔,辻有希子,能登祐一,櫛村由紀恵,蒔田直輝,藤井ちひろ,石井亮太郎,田中章浩,尾原知行,水野敏樹.マイコプラズマ感染後に急性発症した多相性運動ニューロパチー (MMN) の1例.末梢神経,26(2): 394, 2015.

        <学術集会でのプロシーディング>
        1. Shiogai T, Koyama M, Yamamoto M, Arima Y, Maejima R, Kasai T, Mizuno T, Nakagawa M. Correlation of wave intensity analysis in the cervical arteries with intracranial hemodynamics. Clinical Neuroscience. 13(Suppl.1): 35-36, 2016.
        2. 今井啓輔,濱中正嗣,山田丈弘,山﨑英一,五影昌弘,山本敦史,傳 和眞,中村拓真,竹上徹郎,佐藤公俊,梅澤邦彦.血栓除去機器での機械的血栓破砕術にて完全再開通できた急性期脳梗塞例の特徴.The Mt. Fuji Workshop on CVC 34: 128-131.
        3. Nakase T, Suzuki A. The antiplatelet activity of direct oral anticoagulants in acute ischemic stroke patients. Circulation. 134(Suppl.1): A14685, 2016.

ページの先頭へ
ページの先頭へ